Sage Journals: Discover world-class research

Abstract

Background

Systematic reviews examining associations of depressive disorder with coronary heart disease and stroke produce mixed results. Failure to consider reverse causation and dose–response patterns may have caused inconsistencies in evidence.

Design

This prospective cohort study on depressive disorder, coronary heart disease, and stroke analysed reverse causation and dose–response effects using four 5-year and three 10-year observation cycles (total follow up 24 years) based on multiple repeat measures of exposure.

Methods

Participants in the Whitehall II study (n = 10,036, 31,395 person-observations, age at start 44.4 years) provided up to six repeat measures of depressive symptoms via the 30-item General Health Questionnaire (GHQ-30) and one measure via Center for Epidemiologic Studies Depression Scale (CES-D). The cohort was followed up for major coronary events (coronary death/nonfatal myocardial infarction) and stroke (stroke death/morbidity) through the national mortality register Hospital Episode Statistics, ECG-screening, medical records, and self-report questionnaires.

Results

GHQ-30 caseness predicted stroke over 0–5 years (age-, sex- and ethnicity-adjusted HR 1.60, 95% CI 1.1–2.3) but not over 5–10 years (HR 0.94, 95% CI 0.6–1.4). Using the last 5-year observation cycle, cumulative GHQ-30 caseness was associated with incident coronary heart disease in a dose–response manner (1–2 times a case: HR 1.12, 95% CI 0.7–1.7; 3–4 times: HR 2.06, 95% CI 1.2–3.7), and CES-D caseness predicted coronary heart disease (HR 1.81, 95% CI 1.1–3.1).

Conclusions

There was evidence of a dose–response effect of depressive symptoms on risk of coronary heart disease. In contrast, prospective associations of depressive symptoms with stroke appeared to arise wholly or partly through reverse causation.

Keywords

Coronary disease depression prospective study reverse causation stroke

Get full access to this article

View all access options for this article.

References

Murray

Vos

Lozano

. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197–2223.

Lozano

Naghavi

Foreman

. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095–2128.

Nicholson

Kuper

Hemingway

. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763–2774.

Pan

Sun

Okereke

. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA 2011; 306: 1241–1249.

Goldberg

. The detection of psychiatric illness by questionnaire, Oxford: Oxford University Press, 1972.

Radloff

. The CES-D Scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977; 1: 385–401.

Marmot

Brunner

. Cohort profile: the Whitehall II study. Int J Epidemiol 2005; 34: 251–256.

Tunstall-Pedoe

Kuulasmaa

Amouyel

. Myocardial infarction and coronary deaths in the world health organization MONICA project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90: 583–612.

Berger

Hense

Rothdach

. A single question about prior stroke versus a stroke questionnaire to assess stroke prevalence in populations. Neuroepidemiology 2000; 19: 245–257.

10.

Britton

Milne

Butler

. Validating self-reported strokes in a longitudinal UK cohort study (Whitehall II): extracting information from hospital medical records versus the Hospital Episode Statistics database. BMC Med Res Methodol 2012; 12: 83–83.

11.

Stansfeld

Marmot

. Social class and minor psychiatric disorder in British Civil Servants: a validated screening survey using the General Health Questionnaire. Psychol Med 1992; 22: 739–749.

12.

Head

Stansfeld

Ebmeier

. Use of self-administered instruments to assess psychiatric disorders in older people: validity of the General Health Questionnaire, the Center for Epidemiologic Studies Depression Scale and the self-completion version of the revised Clinical Interview Schedule. Psychol Med 2013, pp. 1–8.

13.

Gasse C, Laursen TM and Baune BT. Major depression and first-time hospitalization with ischemic heart disease, cardiac procedures and mortality in the general population: a retrospective Danish population-based cohort study. Eur J Prev Cardiol 2012 (Epub ahead of print).

14.

Vermeer

Longstreth

WT Jr

Koudstaal

. Silent brain infarcts: a systematic review. Lancet Neurol 2007; 6: 611–619.

15.

Alexopoulos

Meyers

Young

. ‘Vascular depression' hypothesis. Arch Gen Psychiatry 1997; 54: 915–922.

16.

Sneed

Culang-Reinlieb

. The vascular depression hypothesis: an update. Am J Geriatr Psychiatry 2011; 19: 99–103.

17.

Pajak

Jankowski

Kotseva

. Depression, anxiety, and risk factor control in patients after hospitalization for coronary heart disease: the EUROASPIRE III Study. Eur J Prev Cardiol 2013; 20: 331–340.

18.

Turner-Stokes

. Poststroke depression: getting the full picture. Lancet 2003; 361: 1757–1758.

19.

Kivimaki

Shipley

Allan

. Vascular risk status as a predictor of later-life depressive symptoms: a cohort study. Biol Psychiatry 2012; 72: 324–330.

20.

McDougall

Brayne

. Systematic review of the depressive symptoms associated with vascular conditions. J Affect Disord 2007; 104: 25–35.

21.

Ramasubbu

. Relationship between depression and cerebrovascular disease: conceptual issues. J Affect Disord 2000; 57: 1–11.

22.

Gimeno

Kivimaki

Brunner

. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med 2009; 39: 413–423.

23.

Emerging Risk Factors Collaboration, Kaptoge S, Lowe G, Pepys MB, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010; 375: 132–140.

24.

Law

Morris

Wald

. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338: b1665–b1665.

25.

Pilgrim

Stansfeld

Marmot

. Low blood pressure, low mood? BMJ 1992; 304: 75–78.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB

Depressive disorder,coronary heart disease,and stroke: dose–response and reverse causation effects in the Whitehall II cohort study

Abstract

Background

Design

Methods

Results

Conclusions

Keywords

Get full access to this article

References

Supplementary Material